Pieces Technologies

Dr. Ruben Amarasingham serves as CEO and Founder. He joined Pieces from an unusual perch—he was previously a practicing physician and executive at Parkland Health & Hospital System, where he also founded the Parkland Center for Clinical Innovation. This dual background means the product roadmap reflects operational pain points inside a safety-net hospital rather than theoretical use cases identified in academic AI labs.

Pieces models are trained on clinically annotated inpatient data drawn from Parkland Health & Hospital System, one of the nation's busiest safety-net hospitals. The firm deployed embedded clinical data scientists who annotated real physician notes, lab values, and social-work assessments. That process created a dataset representing high-acuity, socially complex patients—the population where predictive models have historically been least accurate.

Pieces integrates with Cerner and Epic to surface predictive risk scores within the clinical workflow. The platform generates flags for discharge readiness, 30-day readmission risk, and social needs that might delay safe discharge. Clinicians see these as structured alerts inside their existing charting environment, rather than needing a separate application. The firm's utilization-management module, announced in 2024, extends this logic to payer authorization by aligning clinical documentation with the evidence plans require.

Pieces is a clinical-AI platform company structured to deliver predictive models as an embedded software layer. Deployment requires a health-system partnership that includes data sharing, clinical liaison staffing, and workflow mapping. It is not a pure SaaS vendor selling an out-of-the-box model; each deployment involves initial annotation work and integration with local clinical workflows.

Publicly confirmed clients include Parkland Health & Hospital System, UT Southwestern Medical Center, and Children's Health—all in the Dallas-Fort Worth area. The firm's scaling strategy has prioritized deep local partnerships and multi-year co-development agreements rather than broad but shallow national rollouts. No public disclosures detail deployments beyond Texas.

The firm's predictions align with measures that carry financial penalties or shared-savings upside: avoidable days (length-of-stay), 30-day readmission rates, and missed social-determinant referrals. By focusing on these specific operational metrics, Pieces builds the business case for health systems managing at-risk contracts or facing CMS readmission penalties. The utilization-management module targets payer denials, which have risen sharply as prior-authorization requirements expand.

Pieces raised venture funding from Concord Health Partners, a healthcare-focused growth equity firm, and OSF Ventures, the corporate venture arm of OSF HealthCare. The firm remains privately held, does not disclose revenue or valuation, and has not announced a Series C round or secondary transaction as of mid-2025. The investor profile suggests alignment with strategic health-system partners rather than generalist tech VCs.